EKSO — Ekso Bionics Holdings Income Statement
0.000.00%
Last trade - 00:00- $13.62m
- $12.23m
- $17.93m
- 37
- 57
- 22
- 32
Annual income statement for Ekso Bionics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8.88 | 11.2 | 12.9 | 18.3 | 17.9 |
| Cost of Revenue | |||||
| Gross Profit | 5.07 | 6.75 | 6.21 | 9.08 | 9.51 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 22.2 | 24 | 28.5 | 33.4 | 28.5 |
| Operating Profit | -13.3 | -12.7 | -15.6 | -15.1 | -10.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -15.8 | -9.76 | -15.1 | -15.2 | -11.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -15.8 | -9.76 | -15.1 | -15.2 | -11.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -15.8 | -9.76 | -15.1 | -15.2 | -11.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -15.8 | -10.8 | -15.1 | -15.2 | -11.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.15 | -0.975 | -1.16 | -1.1 | -0.557 |